Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine

The incidence and mortality of pancreatic ductal adenocarcinoma are growing over time. The management of patients with pancreatic ductal adenocarcinoma involves a multidisciplinary team, ideally involving experts from surgery, diagnostic imaging, interventional endoscopy, medical oncology, radiation...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Federica Vernuccio, Carlo Messina, Valeria Merz, Roberto Cannella, Massimo Midiri
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	pancreatic ductal adenocarcinoma pancreatic neoplasm computed tomography (CT) magnetic resonance imaging (MRI) Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/d5a8cc43a3724d368124edf4173de1bd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d5a8cc43a3724d368124edf4173de1bd
record_format	dspace
spelling	oai:doaj.org-article:d5a8cc43a3724d368124edf4173de1bd2021-11-25T17:22:12ZResectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine10.3390/diagnostics111121662075-4418https://doaj.org/article/d5a8cc43a3724d368124edf4173de1bd2021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2166https://doaj.org/toc/2075-4418The incidence and mortality of pancreatic ductal adenocarcinoma are growing over time. The management of patients with pancreatic ductal adenocarcinoma involves a multidisciplinary team, ideally involving experts from surgery, diagnostic imaging, interventional endoscopy, medical oncology, radiation oncology, pathology, geriatric medicine, and palliative care. An adequate staging of pancreatic ductal adenocarcinoma and re-assessment of the tumor after neoadjuvant therapy allows the multidisciplinary team to choose the most appropriate treatment for the patient. This review article discusses advancement in the molecular basis of pancreatic ductal adenocarcinoma, diagnostic tools available for staging and tumor response assessment, and management of resectable or borderline resectable pancreatic cancer.Federica VernuccioCarlo MessinaValeria MerzRoberto CannellaMassimo MidiriMDPI AGarticlepancreatic ductal adenocarcinomapancreatic neoplasmcomputed tomography (CT)magnetic resonance imaging (MRI)Medicine (General)R5-920ENDiagnostics, Vol 11, Iss 2166, p 2166 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	pancreatic ductal adenocarcinoma pancreatic neoplasm computed tomography (CT) magnetic resonance imaging (MRI) Medicine (General) R5-920
spellingShingle	pancreatic ductal adenocarcinoma pancreatic neoplasm computed tomography (CT) magnetic resonance imaging (MRI) Medicine (General) R5-920 Federica Vernuccio Carlo Messina Valeria Merz Roberto Cannella Massimo Midiri Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
description	The incidence and mortality of pancreatic ductal adenocarcinoma are growing over time. The management of patients with pancreatic ductal adenocarcinoma involves a multidisciplinary team, ideally involving experts from surgery, diagnostic imaging, interventional endoscopy, medical oncology, radiation oncology, pathology, geriatric medicine, and palliative care. An adequate staging of pancreatic ductal adenocarcinoma and re-assessment of the tumor after neoadjuvant therapy allows the multidisciplinary team to choose the most appropriate treatment for the patient. This review article discusses advancement in the molecular basis of pancreatic ductal adenocarcinoma, diagnostic tools available for staging and tumor response assessment, and management of resectable or borderline resectable pancreatic cancer.
format	article
author	Federica Vernuccio Carlo Messina Valeria Merz Roberto Cannella Massimo Midiri
author_facet	Federica Vernuccio Carlo Messina Valeria Merz Roberto Cannella Massimo Midiri
author_sort	Federica Vernuccio
title	Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
title_short	Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
title_full	Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
title_fullStr	Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
title_full_unstemmed	Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
title_sort	resectable and borderline resectable pancreatic ductal adenocarcinoma: role of the radiologist and oncologist in the era of precision medicine
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/d5a8cc43a3724d368124edf4173de1bd
work_keys_str_mv	AT federicavernuccio resectableandborderlineresectablepancreaticductaladenocarcinomaroleoftheradiologistandoncologistintheeraofprecisionmedicine AT carlomessina resectableandborderlineresectablepancreaticductaladenocarcinomaroleoftheradiologistandoncologistintheeraofprecisionmedicine AT valeriamerz resectableandborderlineresectablepancreaticductaladenocarcinomaroleoftheradiologistandoncologistintheeraofprecisionmedicine AT robertocannella resectableandborderlineresectablepancreaticductaladenocarcinomaroleoftheradiologistandoncologistintheeraofprecisionmedicine AT massimomidiri resectableandborderlineresectablepancreaticductaladenocarcinomaroleoftheradiologistandoncologistintheeraofprecisionmedicine
_version_	1718412498303975424

Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine

Ejemplares similares